CAPTRUST Financial Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$108K	Buy	+15,637	New	+$121K	﹤0.01%	2803
2024 Q1	–	Sell	-13,943	Closed	-$58.8K	–	2664
2023 Q4	$58.8K	Buy	+13,943	New	+$56.3K	﹤0.01%	2574
2022 Q3	–	Sell	-1,130	Closed	-$12K	–	4014
2022 Q2	$12K	Sell	1,130 -537	-32%	-$5.56K	﹤0.01%	3667
2022 Q1	$19K	Sell	1,667 -173	-9%	-$2.27K	﹤0.01%	3429
2021 Q4	$29K	Buy	1,840 +224	+14%	+$3.9K	﹤0.01%	3051
2021 Q3	$28K	Buy	1,616 +16	+1%	+$280	﹤0.01%	2950
2021 Q2	$34K	Hold	1,600	–	–	﹤0.01%	2759
2021 Q1	$24K	Buy	1,600 +1,495	+1,424%	+$24.2K	﹤0.01%	2898
2020 Q4	$1K	Buy	105 +55	+110%	+$662	﹤0.01%	3322
2020 Q3	$0	Buy	+50	New	+$534	﹤0.01%	3251

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAPTRUST Financial Advisors's VNDA Position: Q1 2026 in Review

CAPTRUST Financial Advisors opened a new position in Vanda Pharmaceuticals (VNDA) in Q1 2026: 15,637 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #2803 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in VNDA as recently as Q4 2023.

CAPTRUST Financial Advisors first reported a position in VNDA in Q3 2020 and has held it in 10 quarters since. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

CAPTRUST Financial Advisors held 15,637 shares of Vanda Pharmaceuticals worth $108K as of Q1 2026.
Vanda Pharmaceuticals was a new CAPTRUST Financial Advisors position in Q1 2026.
Vanda Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2803 holding.
CAPTRUST Financial Advisors first reported a position in Vanda Pharmaceuticals in Q3 2020 and has held it in 10 quarters since.
170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.